Episode
Breaking Trials: SNaPP Trial of Sugammadex, Neostigmine and Postoperative Pulmonary Complications
- Podcast
- TopMedTalk
- Published
- Jun 11, 2026
- Duration seconds
- 1683
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/topmedtalk-410317/episodes/breaking-trials-snapp-trial-of-sugammadex-neostigmine-and-postoperative-pulmonary-complications/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/topmedtalk-410317/breaking-trials-snapp-trial-of-sugammadex-neostigmine-and-postoperative-pulmonary-complications.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Andy Cumpstey and Mike Grocott interview Kate Leslie about the SNaPP study (Sugammadex, Neostigmine, and Postoperative Pulmonary Complications). SNaPP is a pragmatic randomized study run from the University of Melbourne with the ANZCA Clinical Trials Network across 45 sites in Australia, New Zealand, and Hong Kong. Patients aged 40+ having major abdominal or thoracic surgery (≥2 hours, overnight stay) were randomized after induction to reversal with sugammadex or neostigmine, with anesthetists unblinded and encouraged to use quantitative neuromuscular monitoring. In this podcast Andy, Mike and Kate discuss the results and their implications for anaesthetists and healthcare systems. Find the paper here: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00158-X/fulltext -- Join us at Evidence Based Perioperative Medicine (EBPOM) World Congress 2026 in London. Be part of a global conversation as clinicians from around the world gather between 7-9th July at the British Library in London. Three days of evidence-based perioperative medicine, global insights, and expert debate—featuring speakers including Michael Marmot and Ken Rockwood . Register here - https://ebpom.org/product/ebpom-world-congress-2026/